Close
Close
Actinium Receives Positive from EMA for AML
635 views
2.44444444444
2.4 from 9 votes

Executive Chairman of Actinium Pharmaceuticals discusses his company's positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the EU approval pathway for Actinium, an Acute Myeloid Leukemia (AML) drug.

Learn more about:

Access Programs

2.44444444444
2.4 from 9 votes
Free Newsletter
Find a Clinical Trial
Related Videos